This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Buy Stocks for April 19th
by Zacks Equity Research
CYH, SIGI, BFC, IVZ, and PRGS have been added to the Zacks Rank #1 (Strong Buy) List on April 19, 2021.
THC Pitted Against CYH: Which is a Better-Positioned Stock?
by Zacks Equity Research
Both Tenet Healthcare (THC) and Community Health (CYH) are poised to grow in the thriving hospital industry. On comparative evaluation, we try to discover which stock has better chances of prosperity.
Here's Why Investors Should Hold on to Ensign Group (ENSG)
by Zacks Equity Research
Riding high on growing top line and strategic measures, Ensign Group (ENSG) holds potential to reap benefits for investors.
Universal Health (UHS) Ties Up for New Psychiatric Hospital
by Zacks Equity Research
Universal Health's (UHS) affiliate Havenwyck Hospital forms a joint venture with Mercy Heath to construct a new inpatient behavioral health hospital.
Here's Why Momentum Investors Will Love Community Health Systems (CYH)
by Zacks Equity Research
Does Community Health Systems (CYH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Acadia Healthcare (ACHC) Forms JV to Build Behavioral Health Units
by Zacks Equity Research
Acadia Healthcare (ACHC) enters into a joint venture with Geisinger Health to build twin units for offering access to the much-needed behavioral healthcare all across Pennsylvania.
6 Reasons Why Select Medical (SEM) Stock Looks Attractive
by Zacks Equity Research
Select Medical's (SEM) prolific lines of business, top-line growth, proven financial performance and strong cash flow, inorganic growth profile, partnerships with healthcare system giants bode well.
Can Community Health (CYH) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
Community Health (CYH) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Community Health Systems' (CYH) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Community Health Systems, Inc. (CYH).
Here's Why You Should Retain Mednax (MD) in Your Portfolio
by Zacks Equity Research
Riding high on strategic initiatives and telehealth medicine, MEDNAX (MD) holds potential to reap benefits for investors.
Acadia Healthcare (ACHC) Gets Rating Upgrade Post U.K. Unit Sale
by Zacks Equity Research
Acadia Healthcare's (ACHC) numerous ratings get upgraded by Moody's after the divestment of its U.K. operations.
Encompass Health (EHC) Set to Boost South Carolina Footprint
by Zacks Equity Research
Encompass Health (EHC) introduced plans to construct a hospital in South Carolina for offering enhanced rehabilitative care across the state.
Why Is Community Health Systems (CYH) Up 33.5% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mednax (MD) Ties Up With NightLight to Offer Better Pediatric Care
by Zacks Equity Research
Mednax (MD) collaborates with NighLight with an aim to offer enhanced pediatric care in Texas.
Community Health Systems (CYH) Soars 14.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Community Health Systems (CYH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Why Should You Hold HCA Healthcare (HCA) in Your Portfolio?
by Zacks Equity Research
Riding high on a solid 2021 outlook and strategic measures, HCA Healthcare (HCA) has enough potential to reap benefits for investors.
Why Should You Add Community Health (CYH) to Your Portfolio?
by Zacks Equity Research
Riding high on telehealth services and cost-cutting measures, Community Health (CYH) holds potential to reap benefits for investors.
Community Health Systems (CYH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Community Health Systems (CYH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Tenet Healthcare (THC) Unit Extends Services to NorthShore
by Zacks Equity Research
Tenet Healthcare's (THC) unit Conifer extends alliance with NorthShore till 2024 with an aim to offer enhanced revenue cycle services to NorthShore.
Here's Why You Should Bet on Select Medical (SEM) Stock Now
by Zacks Equity Research
Select Medical (SEM) has been gaining momentum from consistent rise in top-line growth, strong U.S. footprint and solid cash generating abilities.
Here's Why You Should Hold on to Universal Health (UHS) Now
by Zacks Equity Research
Riding high on its solid segments and an impressive top line, Universal Health (UHS) holds enough potential to reap benefits for investors.
Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.
Acadia Healthcare (ACHC) Q4 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q4 results reflect progress in its U.S business, which gained from solid volumes, and its solid cost-management policy.
Universal Health (UHS) to Report Q4 Results: What to Expect?
by Zacks Equity Research
Universal Health's (UHS) fourth-quarter results are likely to reflect gain from better revenues.
MEDNAX's (MD) Q4 Earnings Fall Shy of Estimates, Tumble Y/Y
by Zacks Equity Research
MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.